S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
Stock market today: Japan's Nikkei tops 40,000, as investors await China political meeting
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
Stock market today: Japan's Nikkei tops 40,000, as investors await China political meeting
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
Stock market today: Japan's Nikkei tops 40,000, as investors await China political meeting
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
Stock market today: Japan's Nikkei tops 40,000, as investors await China political meeting
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
OTCMKTS:IMUCD

ImmunoCellular Therapeutics (IMUCD) Stock Price, News & Analysis

$0.31
-0.04 (-10.14%)
(As of 10/12/2020)
Today's Range
$0.31
$0.40
50-Day Range
$0.18
$0.40
52-Week Range
$0.16
$0.51
Volume
3,300 shs
Average Volume
6,605 shs
Market Capitalization
$1.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About ImmunoCellular Therapeutics

ImmunoCellular Therapeutics, Ltd. is a clinical-stage company, which engages in the development of immune-based therapies for the treatment of cancers. The company's lead product candidate, ICT-107, is a dendritic cell-based immunotherapy targeting multiple tumor-associated antigens on glioblastoma stem cells. Its pipeline also includes ICT-121, a patient-specific, dendritic cell-based immunotherapy targeting the CD133 antigen on stem cells in recurrent glioblastoma; ICT-140, a patient-specific, dendritic cell-based immunotherapy targeting antigens on ovarian cancer stem cells; and the Stem-to-T-cell research program which engineers the patient's hematopoietic stem cells to generate antigen-specific cancer-killing T cells. The company was founded on January 30, 2006 and is headquartered in Calabasas, CA.

IMUCD Stock Price History

IMUCD Stock News Headlines

See More Headlines
Receive IMUCD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmunoCellular Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:IMUCD
CIK
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.30 million
Optionable
Not Optionable
Beta
1.63
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Gary S. Titus CPA (Age 60)
    Independent Chairman & Corp. Sec.
    Comp: $63k
  • Mr. Sanford J. Hillsberg (Age 71)
    Co-Founder
  • Dr. John S. Yu (Age 56)
    Founder & Director














IMUCD Stock Analysis - Frequently Asked Questions

How have IMUCD shares performed in 2024?

ImmunoCellular Therapeutics' stock was trading at $0.2320 on January 1st, 2024. Since then, IMUCD stock has increased by 33.6% and is now trading at $0.31.
View the best growth stocks for 2024 here
.

How do I buy shares of ImmunoCellular Therapeutics?

Shares of IMUCD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:IMUCD) was last updated on 3/4/2024 by MarketBeat.com Staff